Physician

Kalkidan Genete Bishu, M.D.

According to 2025 Medicare claims, Kalkidan Bishu, M.D. (NPI: 1881887818) practices interventional cardiology in the Duluth, MN-WI market, with the plurality of this provider's patient population coming from St. Louis, MN. This provider's primary affiliated billing organization is ST. MARY'S MEDICAL CENTER (NPI: 1821835851; TIN: 410695604) and primary practice location at 55805-1906. Bishu is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Collaborative ACO 30, LLC (ACO ID: A5483), and Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Bishu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,091 traditional Medicare patients, billed 1,753 HCPCS/CPT codes, and received $102,532 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,429 prescription claims across 592 beneficiaries totaling $616,706 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 13 records totaling $1,890. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $50,318 and ending at $102,532. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,891 to $616,706. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	440	590	$50,318
2017	733	1,375	$119,457
2018	1,235	2,093	$131,085
2019	1,529	2,484	$126,768
2020	1,947	3,005	$109,485
2021	1,446	2,185	$108,805
2022	444	768	$77,845
2023	959	1,450	$80,625
2024	1,091	1,753	$102,532

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	25	52	$3,891
2017	134	623	$33,924
2018	259	1,080	$74,674
2019	317	1,396	$105,273
2020	353	1,765	$169,156
2021	415	2,102	$276,112
2022	434	2,283	$313,417
2023	539	2,789	$414,650
2024	592	3,429	$616,706

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	45	46	$127
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	59	60	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	53	56	$66
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	90	97	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	833	1,018	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	176	9,452	$177,262
Camzyos	Mavacamten	14	345	$97,441
Xarelto	Rivaroxaban	79	4,137	$73,661
Repatha Sureclick	Evolocumab	64	2,940	$54,630
Jardiance	Empagliflozin	43	1,995	$38,293

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$1,890	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kalkidan Genete Bishu, M.D.?

Tedicare shows public-source Medicare data for Kalkidan Genete Bishu, M.D. (NPI 1881887818), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kalkidan Genete Bishu, M.D. have ACO affiliation data?

Kalkidan Genete Bishu, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Kalkidan Genete Bishu, M.D.?

Kalkidan Genete Bishu, M.D. is linked to ST. MARY'S MEDICAL CENTER (billing NPI 1821835851) in the available physician profile data.

Does Kalkidan Genete Bishu, M.D. have Open Payments data?

Kalkidan Genete Bishu, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.